{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05384626",
            "orgStudyIdInfo": {
                "id": "NVL-655-01"
            },
            "organization": {
                "fullName": "Nuvalent Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of NVL-655 in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)",
            "officialTitle": "A Phase 1/2 Study of the Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor NVL-655 in Patients With Advanced NSCLC and Other Solid Tumors (ALKOVE-1)",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-study-of-nvl-in-patients-with-advanced-nsclc-and-other-solid-tumors-harboring-alk-rearrangement-or-activating-alk-mutation-alkove"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-06-09",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-02",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-05-17",
            "studyFirstSubmitQcDate": "2022-05-17",
            "studyFirstPostDateStruct": {
                "date": "2022-05-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-19",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Nuvalent Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Phase 1/2, dose escalation and expansion study designed to evaluate the safety and tolerability of NVL-655, determine the recommended phase 2 dose (RP2D), and evaluate the antitumor activity in patients with advanced ALK- positive (ALK+) NSCLC and other solid tumors.\n\nPhase 1 will evaluate the overall safety and tolerability of NVL-655 and will determine the RP2D and, if applicable, the MTD of NVL-655 in patients with advanced ALK+ solid tumors.\n\nPhase 2 will determine the objective response rate (ORR) as assessed by Blinded Independent Central Review (BICR) of NVL-655 at the RP2D. Secondary objectives will include the duration of response (DOR), time to response (TTR), progression-free survival (PFS), overall survival (OS), and clinical benefit rate (CBR) of NVL-655 in patients with advanced ALK-positive NSCLC and other solid tumors.",
            "detailedDescription": "In Phase 2, study patients will be enrolled into 6 distinct cohorts:\n\n* Cohort 2a: Patients with locally advanced or metastatic NSCLC harboring an ALK rearrangement who have received 1 prior 2nd-generation ALK TKI (ceritinib, alectinib, or brigatinib). Up to 2 prior lines of chemotherapy and/or immunotherapy are allowed.\n* Cohort 2b: Patients with locally advanced or metastatic NSCLC harboring an ALK rearrangement, who have received 2-3 prior ALK TKIs (crizotinib, ceritinib, alectinib, brigatinib, or lorlatinib). Up to 2 prior lines of chemotherapy and/or immunotherapy are allowed.\n* Cohort 2c: Patients with locally advanced or metastatic NSCLC harboring an ALK rearrangement, who have received lorlatinib as the only prior ALK TKI therapy. Up to one prior line of chemotherapy and/or immunotherapy received prior to lorlatinib is allowed.\n* Cohort 2d: Patients with locally advanced or metastatic NSCLC harboring an ALK rearrangement, who are na\u00efve to ALK TKI therapy. Up to one prior line of chemotherapy and/or immunotherapy is allowed.\n* Cohort 2e: Patients with locally advanced or metastatic NSCLC harboring an ALK rearrangement, not eligible for other Phase 2 cohorts.\n* Cohort 2f: Patients with other solid tumors harboring an ALK rearrangement or activating ALK mutation, who have received \u22651 prior systemic anticancer therapy, or for whom no satisfactory standard therapy exists."
        },
        "conditionsModule": {
            "conditions": [
                "Locally Advanced Solid Tumor",
                "Metastatic Solid Tumor"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 470,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Phase 1 dose escalation",
                    "type": "EXPERIMENTAL",
                    "description": "NVL-655 oral daily dosing",
                    "interventionNames": [
                        "Drug: NVL-655"
                    ]
                },
                {
                    "label": "Cohort 2a",
                    "type": "EXPERIMENTAL",
                    "description": "Patients with locally advanced or metastatic NSCLC harboring an ALK rearrangement who have received 1 prior 2nd-generation ALK TKI (ceritinib, alectinib, or brigatinib). Up to 2 prior lines of chemotherapy and/or immunotherapy are allowed.",
                    "interventionNames": [
                        "Drug: NVL-655"
                    ]
                },
                {
                    "label": "Cohort 2b",
                    "type": "EXPERIMENTAL",
                    "description": "Patients with locally advanced or metastatic NSCLC harboring an ALK rearrangement, who have received 2-3 prior ALK TKIs (crizotinib, ceritinib, alectinib, brigatinib, or lorlatinib). Up to 2 prior lines of chemotherapy and/or immunotherapy are allowed.",
                    "interventionNames": [
                        "Drug: NVL-655"
                    ]
                },
                {
                    "label": "Cohort 2c",
                    "type": "EXPERIMENTAL",
                    "description": "Patients with locally advanced or metastatic NSCLC harboring an ALK rearrangement, who have received lorlatinib as the only prior ALK TKI therapy. Up to one prior line of chemotherapy and/or immunotherapy received prior to lorlatinib is allowed.",
                    "interventionNames": [
                        "Drug: NVL-655"
                    ]
                },
                {
                    "label": "Cohort 2d",
                    "type": "EXPERIMENTAL",
                    "description": "Patients with locally advanced or metastatic NSCLC harboring an ALK rearrangement, who are na\u00efve to ALK TKI therapy. Up to one prior line of chemotherapy and/or immunotherapy is allowed.",
                    "interventionNames": [
                        "Drug: NVL-655"
                    ]
                },
                {
                    "label": "Cohort 2e",
                    "type": "EXPERIMENTAL",
                    "description": "Patients with locally advanced or metastatic NSCLC harboring an ALK rearrangement, not eligible for other Phase 2 cohorts.",
                    "interventionNames": [
                        "Drug: NVL-655"
                    ]
                },
                {
                    "label": "Cohort 2f",
                    "type": "EXPERIMENTAL",
                    "description": "Patients with other solid tumors harboring an ALK rearrangement or activating ALK mutation, who have received \u22651 prior systemic anticancer therapy, or for whom no satisfactory standard therapy exists.",
                    "interventionNames": [
                        "Drug: NVL-655"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "NVL-655",
                    "description": "Oral Tablet of NVL-655",
                    "armGroupLabels": [
                        "Cohort 2a",
                        "Cohort 2b",
                        "Cohort 2c",
                        "Cohort 2d",
                        "Cohort 2e",
                        "Cohort 2f",
                        "Phase 1 dose escalation"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Dose limiting toxicities (DLTs) (Phase 1)",
                    "description": "Define the dose limiting toxicities (DLTs)",
                    "timeFrame": "Within the first 21 days of the first NVL-655 dose"
                },
                {
                    "measure": "Recommended Phase 2 Dose (RP2D) (Phase 1)",
                    "description": "To determine the RP2D",
                    "timeFrame": "Within 21 days of last patient dosed during escalation"
                },
                {
                    "measure": "Objective Response Rate (ORR) (Phase 2)",
                    "description": "To determine ORR as assessed by BICR",
                    "timeFrame": "2-3 years after first patient dosed."
                },
                {
                    "measure": "Number of participants with treatment-emergent adverse events, as assessed by CTCAE, V5.0 (Phase 1)",
                    "description": "Incidence and severity of treatment-emergent adverse events (TEAEs)",
                    "timeFrame": "Approximately 3 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Maximum plasma concentration, (Cmax) of NVL-655",
                    "description": "To determine the maximum plasma concentration (Cmax) of NVL",
                    "timeFrame": "Pre-dose and up to 24 hours post-dose"
                },
                {
                    "measure": "Plasma concentration at the end of the dosing interval (Ctau) of NVL-655",
                    "description": "To determine the plasma concentration at the end of the dosing interval (Ctau) of NVL-655",
                    "timeFrame": "Pre-dose and up to 24 hours post-dose"
                },
                {
                    "measure": "Average plasma concentration (Cavg) of NVL-655",
                    "description": "To determine the average plasma concentration (Cavg) of NVL-655",
                    "timeFrame": "Pre-dose and up to 24 hours post-dose"
                },
                {
                    "measure": "Time of maximum concentration (Tmax) of NVL-655",
                    "description": "To determine the time of maximum concentration (Tmax) of NVL-655",
                    "timeFrame": "Pre-dose and up to 24 hours post-dose"
                },
                {
                    "measure": "Area under the curve at the end of the dosing interval (AUCtau) of NVL-655",
                    "description": "To determine the area under the curve at the end of the dosing interval (AUCtau) of NVL-655",
                    "timeFrame": "Pre-dose and up to 24 hours post-dose"
                },
                {
                    "measure": "Area under the curve from time 0 to 24 (AUC0-24) of NVL-655",
                    "description": "To determine the area under the curve from time 0 to 24 (AUC0-24) of NVL-655",
                    "timeFrame": "Pre-dose and up to 24 hours post-dose"
                },
                {
                    "measure": "Area under the curve from time 0 to infinity (AUCinf) of NVL-655",
                    "description": "To determine the area under the curve from time 0 to infinity (AUCinf) of NVL-655",
                    "timeFrame": "Pre-dose and up to 24 hours post-dose"
                },
                {
                    "measure": "Oral clearance (CL/F) of NVL-655",
                    "description": "To determine the oral clearance (CL/F) of NVL-655",
                    "timeFrame": "Pre-dose and up to 24 hours post-dose"
                },
                {
                    "measure": "Volume of distribution (Vz/F) of NVL-655",
                    "description": "To determine the volume of distribution (Vz/F) of NVL-655",
                    "timeFrame": "Pre-dose and up to 24 hours post-dose"
                },
                {
                    "measure": "Half-life (t1/2) of NVL-655",
                    "description": "To determine the half-life (t1/2) of NVL-655",
                    "timeFrame": "Pre-dose and up to 24 hours post-dose"
                },
                {
                    "measure": "Objective response rate (ORR) (Phase 1)",
                    "description": "Determine ORR as assessed by BICR",
                    "timeFrame": "2-3 years after first patient dosed"
                },
                {
                    "measure": "Duration of response (DOR)",
                    "description": "Determine DOR of NVL-655 until radiographic disease progression or death",
                    "timeFrame": "2-3 years after first patient dosed"
                },
                {
                    "measure": "Clinical benefit rate (CBR)",
                    "description": "Determine CBR of NVL-655",
                    "timeFrame": "2-3 years after first patient dosed"
                },
                {
                    "measure": "Time to response",
                    "description": "Determine time to response of NVL-655",
                    "timeFrame": "Approximately 3 years"
                },
                {
                    "measure": "Progression-free survival (PFS)",
                    "description": "Determine PFS of NVL-655 until radiographic disease progression or death",
                    "timeFrame": "2-3 years after first patient dosed"
                },
                {
                    "measure": "Overall survival (OS) (Phase 2)",
                    "description": "Determine OS",
                    "timeFrame": "Approximately 3 years"
                },
                {
                    "measure": "Number of participants with treatment-emergent adverse events, as assessed by CTCAE, V5.0 (Phase 2)",
                    "description": "Incidence and severity of treatment-emergent adverse events (TEAEs)",
                    "timeFrame": "Approximately 3 years"
                },
                {
                    "measure": "Quality of life assessment",
                    "description": "Measure the quality of life in patients with cancer and/or lung cancer.",
                    "timeFrame": "2-3 years after first patient dosed"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age \u226518 years, Phase 2 Cohort 2f only: Age \u226512 years and weighing \\>40 kg.\n2. Phase 1: Histologically or cytologically confirmed locally advanced or metastatic solid tumor with a documented ALK rearrangement or activating ALK mutation.\n3. Phase 2\n\n   1. Phase 2 Cohorts except 2f: Histologically or cytologically confirmed locally advanced or metastatic NSCLC with a documented ALK rearrangement\n   2. Phase 2 Cohort 2f: Histologically or cytologically confirmed locally advanced or metastatic solid tumor with a documented ALK rearrangement or activating ALK mutation detected by certified assay.\n4. Phase 1: Must have evaluable disease (target or nontarget) according to RECIST 1.1 Phase 2: Must have measurable disease according to RECIST 1.1\n5. Adequate organ function and bone marrow reserve\n\nExclusion criteria:\n\n1. Patient's cancer has a known oncogenic driver alteration other than ALK.\n2. Known allergy/hypersensitivity to excipients of NVL-655.\n3. Major surgery within 4 weeks of the study entry\n4. Ongoing or anticancer therapy\n5. Actively receiving systemic treatment or direct medical intervention on another therapeutic clinical study.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "12 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Tina Kehrig",
                    "role": "CONTACT",
                    "phone": "857-357-7000",
                    "email": "clinicaltrials@nuvalent.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Viola Zhu, MD, PHD",
                    "affiliation": "Nuvalent Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of California Irvine Medical Center",
                    "status": "RECRUITING",
                    "city": "Orange",
                    "state": "California",
                    "zip": "92868",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Misako Nagasaka, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.78779,
                        "lon": -117.85311
                    }
                },
                {
                    "facility": "University of California, Davis Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Sacramento",
                    "state": "California",
                    "zip": "95817",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jonathan Riess, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.58157,
                        "lon": -121.4944
                    }
                },
                {
                    "facility": "Stanford Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Stanford",
                    "state": "California",
                    "zip": "94305",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Joel Neal, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.42411,
                        "lon": -122.16608
                    }
                },
                {
                    "facility": "University of Colorado Cancer Center",
                    "status": "RECRUITING",
                    "city": "Denver",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ross Camidge, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.73915,
                        "lon": -104.9847
                    }
                },
                {
                    "facility": "Georgetown University Medical Center",
                    "status": "RECRUITING",
                    "city": "Washington",
                    "state": "District of Columbia",
                    "zip": "20007",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Joshua Reuss, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.89511,
                        "lon": -77.03637
                    }
                },
                {
                    "facility": "University of Miami; Sylvester Cancer Center",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33136",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Gilberto de Lima Lopes, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Winship Cancer Institute, Emory University",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30322",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ticiana Leal, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "University of Chicago Medical Center",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60637",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Marina Garassino, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "John Hopkins University",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21224",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "VIncent Lam, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Mass General Hospital",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Henry Ford Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Detroit",
                    "state": "Michigan",
                    "zip": "48202",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Shirish Gadgeel, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.33143,
                        "lon": -83.04575
                    }
                },
                {
                    "facility": "Washington University School of Medicine Siteman Cancer Center",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63310",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Saiama Waqar, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "Laura & Isaac Perlmutter Cancer Center at NYU Langone Health",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10016",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sally Lau, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Alexander Drilon, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Duke University Medical Center",
                    "status": "RECRUITING",
                    "city": "Durham",
                    "state": "North Carolina",
                    "zip": "27710",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Thomas Stinchcombe, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.99403,
                        "lon": -78.89862
                    }
                },
                {
                    "facility": "OSU Brain & Spine Hospital",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43210",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Logan Roof, MD, MSCR",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                },
                {
                    "facility": "University of Pennsylvania, Abramson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lova Sun, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Sarah Cannon",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37203",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Melissa Johnson, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "MD Anderson Cancer Center",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Fred Hutchinson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98109",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Christina Baik, MD, MPH",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                },
                {
                    "facility": "Royal North Shore Hospital",
                    "status": "RECRUITING",
                    "city": "Saint Leonards",
                    "state": "New South Wales",
                    "zip": "2065",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Nick Pavlakis, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.82344,
                        "lon": 151.19836
                    }
                },
                {
                    "facility": "Princess Alexandra Hospital",
                    "status": "RECRUITING",
                    "city": "Woolloongabba",
                    "state": "Queensland",
                    "zip": "4102",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Kenneth O'Byrne, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -27.48855,
                        "lon": 153.03655
                    }
                },
                {
                    "facility": "Peter MacCallum Cancer Centre",
                    "status": "RECRUITING",
                    "city": "Melbourne",
                    "state": "Victoria",
                    "zip": "3000",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Benjamin Solomon, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -37.814,
                        "lon": 144.96332
                    }
                },
                {
                    "facility": "Cross Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Edmonton",
                    "state": "Alberta",
                    "zip": "T6G 1Z2",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Quincy Siu Chung Chu, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.55014,
                        "lon": -113.46871
                    }
                },
                {
                    "facility": "Princess Margaret Cancer Centre",
                    "status": "RECRUITING",
                    "city": "Toronto",
                    "state": "Ontario",
                    "zip": "M5G 0A3",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Geoffrey Liu, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                },
                {
                    "facility": "Centre Leon Berard",
                    "status": "RECRUITING",
                    "city": "Lyon",
                    "zip": "69373",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Aurelie Swalduz, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.74848,
                        "lon": 4.84669
                    }
                },
                {
                    "facility": "Chu De Nantes",
                    "status": "RECRUITING",
                    "city": "Saint-Herblain",
                    "zip": "44800",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Pauline Hulo, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.21765,
                        "lon": -1.64841
                    }
                },
                {
                    "facility": "Institut Claudius Regaud",
                    "status": "RECRUITING",
                    "city": "Toulouse Cedex",
                    "zip": "31059",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Julien Mazieres, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.60426,
                        "lon": 1.44367
                    }
                },
                {
                    "facility": "Institute Gustave Roussy",
                    "status": "RECRUITING",
                    "city": "Villejuif",
                    "zip": "94805",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Benjamin Besse, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.7939,
                        "lon": 2.35992
                    }
                },
                {
                    "facility": "IRCCS Istituto Tumori \"G. Paolo II\"",
                    "status": "RECRUITING",
                    "city": "Bari",
                    "zip": "70124",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Domenico Galetta, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.11148,
                        "lon": 16.8554
                    }
                },
                {
                    "facility": "Instituto Europeo di Oncologia",
                    "status": "RECRUITING",
                    "city": "Milano",
                    "zip": "20141",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Gianluca Spitaleri, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "Ospedale Santa Maria delle Croci",
                    "status": "RECRUITING",
                    "city": "Ravenna",
                    "zip": "48121",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Chiara Bennati, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.41344,
                        "lon": 12.20121
                    }
                },
                {
                    "facility": "National Cancer Center",
                    "status": "RECRUITING",
                    "city": "Goyang-si",
                    "state": "Gyeonggi-do",
                    "zip": "10408",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Ji-Youn Han, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.65639,
                        "lon": 126.835
                    }
                },
                {
                    "facility": "Seoul National University Hospital",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "state": "Seoul Capital",
                    "zip": "03080",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Dong-wan Kim, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Severance Hospital Yonsei University Health System",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "state": "Seoul Capital",
                    "zip": "03722",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Byoung Chul Cho, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Samsung Medical Center",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "06351",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Myung-Ju Ahn, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "The Netherlands Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Amsterdam",
                    "zip": "1066 CX",
                    "country": "Netherlands",
                    "contacts": [
                        {
                            "name": "Adrianus Joop de Langen, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.37403,
                        "lon": 4.88969
                    }
                },
                {
                    "facility": "University Medical Center Groningen (UMCG)",
                    "status": "RECRUITING",
                    "city": "Groningen",
                    "zip": "9713",
                    "country": "Netherlands",
                    "contacts": [
                        {
                            "name": "AJ Van Der Wekken, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.21917,
                        "lon": 6.56667
                    }
                },
                {
                    "facility": "National University Hospital",
                    "status": "RECRUITING",
                    "city": "Singapore",
                    "zip": "119074",
                    "country": "Singapore",
                    "contacts": [
                        {
                            "name": "Ross Soo, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 1.28967,
                        "lon": 103.85007
                    }
                },
                {
                    "facility": "National Cancer Centre Singapore",
                    "status": "RECRUITING",
                    "city": "Singapore",
                    "zip": "168583",
                    "country": "Singapore",
                    "contacts": [
                        {
                            "name": "Aaron Tan, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 1.28967,
                        "lon": 103.85007
                    }
                },
                {
                    "facility": "Complejo Hospitalario Universitario de A Coruna",
                    "status": "RECRUITING",
                    "city": "A Coru\u00f1a",
                    "zip": "15006",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Maria Campelo, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.37135,
                        "lon": -8.396
                    }
                },
                {
                    "facility": "UOMI Cancer Center",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08017",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Santiago Viteri Ramirez, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Vall d'Hebron",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08035",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Enriqueta Felip, Md, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Hospital General Universitario Gregorio Maranon",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28007",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Antonio Calles, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Universitario 12 de Octubre",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28041",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Luis Paz Ares, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "National Cheng Kung University Hospital",
                    "status": "RECRUITING",
                    "city": "Tainan",
                    "zip": "70403",
                    "country": "Taiwan",
                    "contacts": [
                        {
                            "name": "Chien-Chung Lin, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 22.99083,
                        "lon": 120.21333
                    }
                },
                {
                    "facility": "National Taiwan University Hospital",
                    "status": "RECRUITING",
                    "city": "Taipei",
                    "zip": "100",
                    "country": "Taiwan",
                    "contacts": [
                        {
                            "name": "Chia-Chi Lin, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                },
                {
                    "facility": "Royal Marsden Hospital",
                    "status": "RECRUITING",
                    "city": "Sutton",
                    "state": "Surrey",
                    "zip": "SM2 5PT",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Anna Minchom, MB BCh MRCP MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.35,
                        "lon": -0.2
                    }
                },
                {
                    "facility": "Edinburgh Cancer Centre",
                    "status": "RECRUITING",
                    "city": "Edinburgh",
                    "zip": "EH4 2XU",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Colin Barrie, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 55.95206,
                        "lon": -3.19648
                    }
                },
                {
                    "facility": "The Christie NHS Foundation Trust",
                    "status": "RECRUITING",
                    "city": "Manchester",
                    "zip": "M20 4BX",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Matthew Krebs, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.48095,
                        "lon": -2.23743
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11220",
                    "name": "Lymphoma",
                    "relevance": "LOW"
                },
                {
                    "id": "T3543",
                    "name": "Lymphosarcoma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M2853",
                    "name": "Immunomodulating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M1825",
                    "name": "Crizotinib",
                    "relevance": "LOW"
                },
                {
                    "id": "M145666",
                    "name": "Alectinib",
                    "relevance": "LOW"
                },
                {
                    "id": "M81041",
                    "name": "Ceritinib",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                }
            ]
        }
    },
    "hasResults": false
}